Careium AB (Publ)
SSE:CARE.ST
25 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 201.7 | 229.4 | 210.7 | 199.4 | 217.3 | 213.8 | 194 | 196.2 | 175.9 | 174.4 | 178.5 | 162.4 | 140.2 | 147 | 138 | 144.7 |
| Cost of Revenue
| 115.4 | 133.8 | 120.4 | 119.2 | 122.8 | 123.6 | 118.5 | 118.9 | 114.8 | 109.2 | 108.5 | 96.5 | 84.7 | 85.9 | 80.2 | 87.4 |
| Gross Profit
| 86.3 | 95.6 | 90.3 | 80.2 | 94.5 | 90.2 | 75.5 | 77.3 | 61.1 | 65.2 | 70 | 65.9 | 55.5 | 61.1 | 57.8 | 57.3 |
| Gross Profit Ratio
| 0.428 | 0.417 | 0.429 | 0.402 | 0.435 | 0.422 | 0.389 | 0.394 | 0.347 | 0.374 | 0.392 | 0.406 | 0.396 | 0.416 | 0.419 | 0.396 |
| Reseach & Development Expenses
| 8.1 | 6.3 | 4.2 | 4.7 | 8.1 | 4.2 | 2.7 | 5 | 4.5 | 4 | 4.1 | 6.6 | 4.9 | 5.4 | 4.2 | 6.4 |
| General & Administrative Expenses
| 23 | 28.3 | 26.5 | 22.6 | 31.8 | 33.9 | 30.2 | 27.7 | 37.7 | 39.8 | 55.8 | 38.7 | 24 | 21.4 | 20 | 21.7 |
| Selling & Marketing Expenses
| 39.2 | 41.3 | 40.5 | 37.3 | 34.4 | 37.8 | 35.8 | 39 | 37.8 | 36.3 | 35.5 | 31.1 | 31.1 | 29.4 | 28.8 | 24.9 |
| SG&A
| 62.2 | 69.6 | 67 | 59.8 | 66.2 | 71.7 | 66 | 66.7 | 75.5 | 76.1 | 91.3 | 69.8 | 55.1 | 50.8 | 48.8 | 46.6 |
| Other Expenses
| -0.6 | -2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 69.7 | 73.8 | 71.2 | 64.5 | 73.9 | 75.5 | 68.2 | 64.1 | 79.4 | 51.9 | 94.3 | 66.4 | 58.2 | 55.1 | 52.6 | 51 |
| Operating Income
| 16.5 | 21.8 | 19.1 | 15.7 | 20.7 | 14.6 | 7.4 | 22.3 | -18.2 | 13.5 | -24.3 | 5.3 | -7.9 | 6 | 5.2 | 26.8 |
| Operating Income Ratio
| 0.082 | 0.095 | 0.091 | 0.079 | 0.095 | 0.068 | 0.038 | 0.114 | -0.103 | 0.077 | -0.136 | 0.033 | -0.056 | 0.041 | 0.038 | 0.185 |
| Total Other Income Expenses Net
| -2.4 | -3.8 | -0.5 | -6 | -5.1 | 4.9 | 0.6 | -7.8 | -1.5 | 0.8 | -0.2 | -3.6 | 5 | -0.6 | -0.2 | -21.1 |
| Income Before Tax
| 14.1 | 18 | 18.6 | 9.7 | 15.6 | 19.5 | 8 | 14.5 | -19.7 | 14.3 | -24.5 | 1.7 | -2.9 | 5.4 | 5 | 5.7 |
| Income Before Tax Ratio
| 0.07 | 0.078 | 0.088 | 0.049 | 0.072 | 0.091 | 0.041 | 0.074 | -0.112 | 0.082 | -0.137 | 0.01 | -0.021 | 0.037 | 0.036 | 0.039 |
| Income Tax Expense
| 3.3 | 4.1 | 4.3 | 2.3 | 3.5 | 4.5 | 1.8 | 5.3 | -4.1 | -2.9 | -5.1 | 2.6 | -0.6 | 1.2 | 1.3 | 2 |
| Net Income
| 10.8 | 13.2 | 13.5 | 6.6 | 12.1 | 14.3 | 5.6 | 11.3 | -16.3 | 17.2 | -19.4 | -1.1 | -2.2 | 4.2 | 3.8 | 3.7 |
| Net Income Ratio
| 0.054 | 0.058 | 0.064 | 0.033 | 0.056 | 0.067 | 0.029 | 0.058 | -0.093 | 0.099 | -0.109 | -0.007 | -0.016 | 0.029 | 0.028 | 0.026 |
| EPS
| 0.41 | 0.54 | 0.56 | 0.27 | 0.47 | 0.59 | 0.23 | 0.35 | -0.67 | 0.71 | -0.8 | -0.046 | -0.09 | 0.18 | 0.16 | 0.15 |
| EPS Diluted
| 0.41 | 0.54 | 0.56 | 0.27 | 0.47 | 0.59 | 0.23 | 0.35 | -0.67 | 0.71 | -0.8 | -0.046 | -0.09 | 0.18 | 0.16 | 0.15 |
| EBITDA
| 34.2 | 37.7 | 34.9 | 34.5 | 44.1 | 33 | 25.5 | 57.8 | 0.9 | 31.4 | -5.4 | 19.6 | 9.7 | 19.5 | 18.4 | 19 |
| EBITDA Ratio
| 0.17 | 0.164 | 0.166 | 0.173 | 0.203 | 0.154 | 0.131 | 0.295 | 0.005 | 0.18 | -0.03 | 0.121 | 0.069 | 0.133 | 0.133 | 0.131 |